Pharmacovigilance Department — Osaka, Osaka

Public research footprint of Pharmacovigilance Department, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Antidiuretic Hormone, Inappropriate Secretion · Bipolar Disorder I · Migraine Disorders · Heart Failure

Recently updated registry entries

NCT04790175 — Samsca Post-marketing General Drug Use-results Survey in Patients With Hyponatremia in… (Active Not Recruiting)
NCT05342493 — Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use (Recruiting)
NCT05712746 — Samtasu Post-marketing General Drug Use-results Survey in Patients With Volume Overload… (Active Not Recruiting)

Work at Pharmacovigilance Department?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.